Curriculum Objective
Objective
General Objectives
General Objectives
Describe the mechanism of action for the drugs used in the treatment of Parkinsonism.
Curriculum Block
Part 4 / Medical Foundation 4 / Neuroscience
- Indicates most relevant
Activities
Tutorial
Tags
Basic Sciences
Pharmacology
Curriculum Block
Part 4
Medical Foundation 4
Neuroscience
Curriculum Week
Part 4
Discipline
Neurology
Pharmacology
Longitudinal Discipline
Clinical Pharmacology
MCC Presentations
Movement Disorders, Involuntary / Tic Disorders
McMaster Program Competencies
2.2 Apply biomedical scientific principles fundamental to health care for patients and populations.
2.3 Apply principles of clinical sciences to diagnostic and therapeutic decision-making, clinical problem-solving, and other aspects of evidence-based healthcare
1.5 Develop and carry out patient management plans
MeSH
Antiparkinson Agents [D27.505.954.427.090.050]
Anti-Dyskinesia Agents [D27.505.954.427.090]
Pharmacologic Actions [D27.505]
Parkinson Disease [C10.574.812]
Movement Disorders [C10.228.662]
Parkinsonian Disorders [C10.228.662.600]
Central Nervous System Agents [D27.505.954.427]
Parkinson Disease [C10.228.662.600.400]
Parkinsonian Disorders [C10.228.140.079.862]
Parkinson Disease [C10.228.140.079.862.500]
